Advertisement

Topics

J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism

20:00 EDT 9 May 2019 | BioSpace

Johnson & Johnson has lost several major lawsuits over allegations that asbestos in its talcum powder contributes to ovarian cancer.

Original Article: J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism

NEXT ARTICLE

More From BioPortfolio on "J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...